VBI Vaccines (NASDAQ:VBIV) Research Coverage Started at Stoc

StockNews.com assumed coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a research note issued to investors on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. VBI Vaccines Price Performance VBIV opened at $0.67 on Tuesday. The stock’s 50 day moving average price is $0.62 and its 200 day […]

Related Keywords

, Frontier Wealth Management , Vaccines Inc , Renaissance Technologies , Millennium Management , Free Report , Street Corp , Financial Advisors , Wealth Management , Get Free Report , Vbi Vaccines , Nasdaq Vbiv , Vbiv , Medical , Initiated Coverage , Stocknews Com ,